Printer Friendly

Valent Biosciences Corporation Acquires Certis USA's Public Health Business; Company Strengthens Leadership Position in Bt Insecticides.

LIBERTYVILLE, Ill. -- LIBERTYVILLE, Ill., March 12 /PRNewswire/ -- Valent BioSciences today announced it has acquired the worldwide public health business of Certis USA, including the Teknar(R) brands of insecticide products that control mosquito and black fly larvae. In addition, the company has licensed worldwide marketing rights for Thuricide(R) biological insecticide for exclusive use in forestry markets from Certis USA. Terms of the acquisition and licensing agreements were not disclosed.

The agreements strengthen Valent BioSciences' leadership position in insecticides based on the naturally occurring bacterium Bacillus thuringiensis (Bt), especially in the area of public health, according to Mike Donaldson, president of the company. Valent BioSciences currently markets leading Bt brands in the public health, forestry and agricultural market segments.

"We have seen substantial growth of our public health business in recent years due to the increased use of biorational products for mosquito control to prevent the spread of disease, especially West Nile virus, dengue fever and malaria," Donaldson says. "The acquisition of Certis USA's public health business expands our market offering for the public health segment and gives us an even more robust Bt technology base for all the market segments we serve."

As part of the public health business transaction, Valent BioSciences acquired Bt israelensis strains, patents, trademarks, registrations, manufacturing processes, R&D programs, and customer contracts. The licensing agreement for Thuricide insecticide, which controls Lepidopteran insect larvae such as the gypsy moth and spruce budworm, involves exclusive forestry marketing rights worldwide. Under the agreements, Certis USA will continue manufacturing the products.

"The public health, forestry and agricultural markets are all of strategic importance to Valent BioSciences," Donaldson says. "We're confident that the technology base represented by both the Teknar and Thuricide agreements will yield new products for our customers in the future."

Valent BioSciences, headquartered in Libertyville, Illinois, is a worldwide leader in the research, development and commercialization of low risk, environmentally compatible technologies and products for the agricultural, public health, forestry and household insecticide markets. For more information on the products offered by Valent BioSciences, please visit http://www.valentbiosciences.com/ .

CONTACT: Mike Donaldson of Valent BioSciences Corporation, +1-847-968-4701, or Doug Jeske of The Meyocks Group, +1-515-327-3429

Web site: http://www.valentbiosciences.com/
COPYRIGHT 2003 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Geographic Code:1USA
Date:Mar 12, 2003
Words:366
Previous Article:Hitachi Data Systems Selects Sprint for Global Communications Services; Sprint Wins Voice and Data Services in Three-Year Agreement.
Next Article:Firstlogic Directory Retrieval Software (DRS) and Video Coding System (VCS) Selected by Lockheed Martin for U.S. Postal Service Project.


Related Articles
Sumitomo Chemical Completes Acquisition of Abbott Laboratories' Agricultural Products Business.
Synergies Realized for Valent U.S.A. and Valent BioSciences.
Sumitomo Chemical Acquires Aventis' Household Insecticide Business.
Valent BioSciences Licenses Improved Bt Toxin Testing Technology to Agdia; Faster, Consistent Identification of Widely Used Bt Toxins.
Valent BioSciences Licenses DeVine(R) Biological Herbicide to Encore Technologies; Effective Tool Available to Florida Citrus Growers.
Valent BioSciences and FMC FoodTech Announce Collaborative Agreement on Plant Growth Regulators.
Certis USA to Acquire Certain Assets of Ecogen, Inc.
Certis USA, LLC, Columbia, Md., a wholly owned subsidiary of Mitsui & Co., Ltd. and a leading producer of biological pesticides, plans to acquire...
Valent BioSciences Corporation Licenses Proprietary PGR Technology.
Valent BioSciences Corporation Chooses i-Sight Complaint Handling Software And Corrective Action Software.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters